The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.
Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.
A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.
A new treatment for people with multiple myeloma will now be available on the NHS in England.